In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006)

Journal of the American Veterinary Medical Association

Volumn 231, Issue 7, 2007, Pages 1086-1091

  Ledbetter, Eric C ^a   Patten, Valeri H ^a   Scarlett, Janet M ^a   Vermeylen, Francoise M ^b  

^a Plant Science Building   (United States)

^b Department of Molecular Biology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANIMAL; ANIMAL DISEASE; ANTIFUNGAL RESISTANCE; DOSE RESPONSE; DRUG EFFECT; FEMALE; FUNGAL EYE INFECTION; FUNGUS; HORSE; HORSE DISEASE; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; UNITED STATES;

ANIMALS; ANTIFUNGAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, FUNGAL; EYE INFECTIONS, FUNGAL; FEMALE; FUNGI; HORSE DISEASES; HORSES; MALE; MICROBIAL SENSITIVITY TESTS; NEW ENGLAND; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

ANIMALIA; ASPERGILLUS; CANDIDA; EQUIDAE; FUNGI; FUSARIUM;

EID: 35548969387     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.231.7.1086     Document Type: Review

References (50)

1. Gaarder JE, Rebhun WC, Ball MA, et al. Clinical appearances, healing patterns, risk factors, and outcomes of horses with fungal keratitis: 53 cases (1978-1996). J Am Vet Med Assoc 1998; 213:105-112.
2. Andrew SE, Brooks DE, Smith PJ, et al. Equine ulcerative keratomycosis: visual outcome and ocular survival in 39 cases (1987-1996). Equine Vet J 1998;30:109-116.
3. Grahn B, Wolfer J, Keller C, et al. Equine keratomycosis: clinical and laboratory findings in 23 cases. Prog Vet Comp Ophthalmol 1993;3:2-7.
4. Barton MH. Equine keratomycosis. Compend Contin Educ Pract Vet 1992;14:936-944.
5. Sansom J, Featherstone H, Barnett KC. Keratomycosis in six horses in the United Kingdom. Vet Rec 2005;156:13-17.
6. Hendrix DVH, Brooks DE, Smith PJ, et al. Corneal stromal abscesses in the horse: a review of 24 cases. Equine Vet J 1995;27:440-447.
7. Brooks DE, Andrew SE, Denis HM, et al. Rose bengal positive epithelial microerosions as a manifestation of equine keratomycosis. Vet Ophthalmol 2000;3:83-86.
8. Bistner SI, Riis RC. Clinical aspects of mycotic keratitis in the horse. Cornell Vet 1979;69:364-374.
9. Brooks DE, Andrew SE, Dillavou CL, et al. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis. Am J Vet Res 1998;59:138-142.
10. Coad CT, Robinson NM, Wilhelmus KR. Antifungal sensitivity testing for equine keratomycosis. Am J Vet Res 1985;46:676-678.
11. Moore CP, Heller N, Majors LJ, et al. Prevalence of ocular microorganisms in hospitalized and stabled horses. Am ] Vet Res 1988;49:773-777.
12. McLaughlin SA, Brightman AH, Helper LC, et al. Pathogenic bacteria and fungi associated with extraocular disease in the horse. J Am Vet Med Assoc 1983;182:241-242.
13. Moore CP, Fales WH, Whittington P, et al. Bacterial and fungal isolates from Equidae with ulcerative keratitis. J Am Vet Med Assoc 1983;182:600-603.
14. Hamilton HL, McLaughlin SA, Whitley EM, et al. Histologic findings in corneal stromal abscesses of 11 horses: correlation with cultures and cytology. Equine Vet J 1994;26:448-453.
15. Beech J, Sweeney CR, Irby N. Keratomycoses in 11 horses. Equine Vet J 1983;Suppl 2:39-44.
16. Hodgson DR, Jacobs KA. Two cases of fusarium keratomycosis in the horse. Vet Rec 1982;110:52-522.
17. Richter M, Hauser B, Kaps S, et al. Keratitis due to Histoplasma spp in a horse. Vet Ophthalmol 2003;6:99-103.
18. Friedman DS, Schoster JV, Pickett JP, et al. Pseudalkscheria boydii keratomycosis in a horse. J Am Vet Med Assoc 1989;195:616-618.
19. Shadomy HJ, Dixon DM. A new Papulaspora species from the infected eye of a horse: Papulaspora equl sp. nov. Mycopathologia 1989;106:35-39.
20. Moore CP, Collins K, Fales WH. Antibacterial susceptibility patterns for microbial isolates associated with infectious keratitis in horses: 63 cases (1986-1994). J Am Vet Med Assoc 1995;207:928-933.
21. Andrew SE, Nguyen A, Jones GL, et al. Seasonal effects on the aerobic bacterial and fungal conjunctival flora of normal thoroughbred brood mares in Florida. Vet Ophthalmol 2003;6: 45-50.
22. Samuelson DA, Andresen TL, Gwin RM. Conjunctival fungal flora in horses, cattle, dogs, and cats. J Am Vet Med Assoc 1984;184:1240-1242.
23. Gemensky-Metzler AJ, Wilkie DA, Kowalski JJ, et al. Changes in bacterial and fungal ocular flora of clinically normal horses following experimental application of topical antimicrobial or antimicrobial-corticosteroid ophthalmic preparations. Am J Vet Res 2005;66:800-811.
24. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003;16:730-797.
25. Vemuganti GK, Garg P Gopinathan U, et al. Evaluation of agent and host factors in progression of mycotic keratitis. Ophthalmology 2002;109:1538-1546.
26. United States Census Bureau Web site. Geographic areas reference manual. Available at: www.census.gov/geo/www/garm. html. Accessed Jan 23, 2007.
27. National Committee for Clinical Laboratory Standards. In: Methods for antifungal disk diffusion susceptibility testing of yeasts; approved guidelines M44-A. Wayne, Pa: Clinical and Laboratory Standards Institute, 2004.
28. Forrest G. Role of antifungal susceptibility testing in patient management. Curr Opin Infect Dis 2006;19:538-543.
29. Ball MA, Rebhun WC, Trepanier L, et al. Corneal concentrations and preliminary toxicological evaluation of an intraconazole/dimethyl sulphoxide ophthalmic ointment. J Vet Pharmacol Ther 1997;20:100-104.
30. Kowalski RP, Yates KA, Romanowski EG, et al. An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data. Ophthalmology 2005;112:1987e1-1987e6.
31. Stratton CW. In vitro susceptibility testing versus in vivo effectiveness. Med Clin North Am 2006;90:1077-1088.
32. Odds FC, Van Gerven F, Espinel-Ingroff A, et al. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antlmicrob Agents Chemother 1998;42:282-288.
33. Espinel-Ingroff A. Utility of mould susceptibility testing. Curr Opin Infect Dis 2003;16:527-532.
34. Odds FC. Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response? Drug Resist Updat 1998;1:11-15.
35. Rex JH, Pfaller MA, Walsh TJ, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 2001;14:643-658.
36. O'Day DM. Selection of appropriate antifungal therapy. Cornea 1987;6:238-245.
37. Leek AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002;86:1211-1215.
38. Pfaller MA, Messer SA, Boyken L, et al. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002. J Clin Microbiol 2004;42: 3142-3146.
39. Bartizal C, Odds FC. Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus. Antimicrob Agents Chemother 2003;47:2100-2107.
40. Matar MJ, Ostrosky-Zeichner L, Paetznick VL, et al. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother 2003;47:1647-1651.
41. Karaca N, Koc AN. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods. Diagn Microbiol Infect Dis 2004;48:259-264.
42. Serrano MC, Ramirez M, Morilla D, et al. A comparative study of the disk diffusion method with the broth microdilution and E-test methods for voriconazole susceptibility testing of Aspergillus species. J Antimicrob Chemother 2004;53:739-742.
43. Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 2000;19:307-312.
44. Ritterband DC, Seedor JA, Shah MK, et al. Fungal keratitis at the New York Eye and Ear Infirmary. Cornea 2006;25:264-267.
45. Kelly LD, Pavan-Langston D, Baker AS. Keratomycosis in a New England referral center: spectrum of pathogenic organisms and predisposing factors. In: Bialasiewics AA, Schaal KP, eds. Infectious diseases of the eye. Boston: Butterworth-Heinemann, 1994; 190-194.
46. Rosa RH, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in South Florida. Ophthalmology 1994;101: 1005-1013.
47. Ishibashi Y, Hommura S, Matsumoto Y. Direct examination vs culture of biopsy specimens for the diagnosis of keratomycosis. Am J Ophthalmol 1987;103:636-640.
48. Timoney JF, Gillespie JH, Scott FW, et al. The opportunistic fungal infections. In: Timoney JF, Gillespie JH, Scott FW, et al, eds. Hagan and Bruner's microbiology and infectious diseases of domestic animals. 8th ed. Ithaca, NY: Cornell University Press, 1988;407-424.
49. O'Day DM, Head WS, Robinson RD, et al. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res 1986;5:877-882.
50. Betbeze CM, Wu CC, Krohne SG, et al. In vitro fungistatic and fungicidal activities of silver sulfadiazine and natamycin on pathogenic fungi isolated from horses with keratomycosis. Am J Vet Res 2006;67:1788-1793.